How does Biogen Chief Medical Officer Al Sandrock feel after the curtain was lifted on clinical trial data of the experimental Alzheimer’s drug his company is developing with Japanese drugmaker Eisai?
WASHINGTON — When titans of the pharmaceutical industry met here last week at the opulent Mandarin Oriental Hotel, Trump administration officials issued a blunt warning to the chief executives on the prices
Swiss drugmaker Novartis has announced that it will shelve price increases for medicines in the US after criticism of the sector from President Donald Trump over rising costs. “We have voluntarily pulled
Microsoft cofounder Bill Gates revealed more of his plan to invest in Alzheimer’s disease research on Tuesday. He along with fellow billionaire Leonard Lauder, the Dolby family, the Charles and Helen Foundation
WASHINGTON/NEW YORK (Reuters) - Pfizer Inc (PFE.N) said on Tuesday it was deferring drug price increases for no more than six months after the company’s chief executive officer had an extensive conversation
China has vowed to speed up cuts to the cost of cancer drugs in a move that threatens to dent revenues in the country for multinationals such as Eli Lilly, Roche and Novartis. Officials will “accelerate
This story was written by Matthew Herper and Michela Tindera. The indictment of Theranos founder Elizabeth Holmes, and the barrage of shocking details about her company unearthed by John Carreyrou in best-selling
A complicated new clinical trial could give some hope to Alzheimer’s patients and investors in drug companies. But there are lots of devilish details. Drugmakers Biogen and Eisai said the top dose of experimental